Although recent in vitro studies have suggested that SPRED3 could serve as a potential biomarker in thyroid carcinoma, the physiological role and molecular mechanism of SPRED3 in this context have yet to be fully elucidated [10,11]. The gene discussed is SPRED3; the disease is thyroid gland carcinoma.